Compositions and methods for monosynaptic transport
AssigneeThe Salk Institute for Biological Studies
InventorsIan R. Wickersham, John A.T. Young, Edward M. Callaway
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Salk Institute for Biological Studies
InventorsIan R. Wickersham, John A.T. Young, Edward M. Callaway
Estimating the term…
Disclosed herein are methods of expressing a heterologous nucleic acid sequence, such as a sequence encoding a detectable protein, in a primary neuron (or plurality of primary neurons) and other neurons that are monosynaptically connected to the primary neuron (or plurality of primary neurons). Such methods involve viruses (such as, rabies viruses) defective for transsynaptic transport (TST-defective virus) and in situ complementation of the defect in a manner that permits only monosynaptic transport of the TST-defective virus. The TST-defective virus and, therefore, any heterologous nucleic acid sequence it carries in its genome, are not transmitted to neurons that are not monosynaptically connected to the primary neuron (or plurality of primary neurons). Also disclosed are methods of targeting a TST-defective virus to a genetically defined primary neuron (or plurality of primary neurons). The disclosed technology enables far more specific labelling and/or manipulation of neural networks than has previously been possible.
A neuron labeling method, comprising:
A neuron labeling method, comprising:
A neuron labeling method, comprising:
A method for monosynaptic transport of a virus defective for transsynaptic transport (TST-defective virus), comprising contacting one or more primary neurons, each of which is connected by a plurality of synapses to a plurality of secondary neurons, with:
A kit for neuronal labeling, comprising:
Dependencies are inferred from the claim text.